Benzylamine Antifungal

This page covers all Benzylamine Antifungal drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cytochrome P450 2D6, Fungal sterol synthesis (squalene epoxidase inhibition).

Targets

Cytochrome P450 2D6 · Fungal sterol synthesis (squalene epoxidase inhibition)

Marketed (1)

• Mentax · Bayer · Infectious Disease

Phase 3 pipeline (1)

• NAFT-500 · Merz North America, Inc. · Dermatology
  NAFT-500 is a naftifine derivative designed to modulate skin barrier function and reduce inflammation in dermatological conditions.

Patent intelligence

• benzylamine antifungal patent landscape — aggregated cliff calendar, attackable patents, originator estates